JPMorgan downgraded Cognex (CGNX) to Underweight from Neutral with a price target of $35, down from $45. The firm cites the stock’s “stretched” valuation and cyclical risks facing the company for the downgrade. While Cognex’s strategic transformation and innovation should support future growth, the stock’s current premium to historical multiples “warrants caution,” the analyst tells investors in a research note.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGNX:
- Cognex price target raised to $38 from $35 at DA Davidson
- Cognex Earnings Call: Strong Growth Amid Challenges
- Cognex’s Growth Potential and Operational Efficiency Support Buy Rating
- Cognex price target raised to $45 from $43 at Baird
- Cognex’s Strategic Growth and Profitability Reinforce Buy Rating Amid Macroeconomic Concerns